Validity, reliability, and sensitivity-to-change properties of the psoriatic arthritis screening and evaluation questionnaire
- 15 July 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Archiv für dermatologische Forschung
- Vol. 301 (8), 573-579
- https://doi.org/10.1007/s00403-009-0981-3
Abstract
Psoriatic arthritis (PsA) is an inflammatory arthritis associated with irreversible joint damage in a subset of individuals. There is a need to screen early for this condition to prevent damage. To meet this need, we have developed the psoriatic arthritis screening and evaluation (PASE) questionnaire. The 15-item PASE questionnaire was administered to 190 individuals with either psoriasis or PsA. The PASE questionnaire was readministered to a subset of individuals with PsA in order to assess test–retest reliability and sensitivity-to-change. Receiver operator curves were constructed to optimize sensitivity and specificity for the diagnosis of PsA. Of the 190 participating in the study, 19.5% (37/191) participants were diagnosed with PsA. PASE total scores ranged from 15 to 74 (possible range, 15–75). The PsA group had a median Total score of 51 (25th and 75th percentile 44 and 57), and non-PsA group had a median total score of 34 (25th and 75th percentile 21 and 49) (p < 0.001). A PASE total score of 44 was able to distinguish PsA from non-PsA participants with 76% sensitivity and 76% specificity. Furthermore, 13 of the 15 items demonstrated significant test–retest reliability as assessed by Pearson correlation coefficient (r ≥ 0.5). PASE was sensitive-to-change with therapy; PASE scores were significantly lower for PsA individuals after systemic therapy (p < 0.034). The PASE questionnaire is a valid and reliable tool to screen for active PsA among individuals with psoriasis. PASE scores may be used as a marker of therapeutic response.Keywords
This publication has 20 references indexed in Scilit:
- Development and initial validation of a screening questionnaire for psoriatic arthritis: the Toronto Psoriatic Arthritis Screen (ToPAS)Annals Of The Rheumatic Diseases, 2008
- The PASE questionnaire: Pilot-testing a Psoriatic Arthritis Screening and Evaluation toolJournal of the American Academy of Dermatology, 2007
- Clinical characteristics of psoriatic arthritis and psoriasis in dermatologists' officesJournal of Dermatological Treatment, 2006
- Epidemiology of psoriatic arthritis in the population of the United StatesJournal of the American Academy of Dermatology, 2005
- Genetic epidemiology of psoriasis and psoriatic arthritisAnnals Of The Rheumatic Diseases, 2005
- Psoriatic arthritis: epidemiology, clinical features, course, and outcomeAnnals Of The Rheumatic Diseases, 2005
- Diagnosis and treatment of psoriatic arthritisJournal of the American Academy of Dermatology, 2005
- Psoriatic arthritisDermatologic Therapy, 2004
- Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective studyRheumatology, 2003
- Psoriatic arthritis: performance of rheumatologists in daily practiceAnnals Of The Rheumatic Diseases, 2002